Refrences
- Grear JP, Foerster J, Lukems JN, Rodgers GM, Paraskavas F, Glader B. Myelofibrosis. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B. (eds) Wintrobe's Clinical Hematology, 11th ed. Philadelphia: Lippincott Williams & Wilkins, 2004; 2273-2284.
- Heuck G. Zwei Fälle Von Leukemie mit eigenthum licken blut-respKnockenmarks be fund. Arch Pathol Anat Physiol Virchows 1879; 78: 475–496.
- Hasselbalch H. Idiopathic myelofibrosis: A clinical study of 80 patients. Am J Hemat 1990; 34: 291–300.
- Rielly JT. Pathogenesis of idiopathic myelofibrosis: role of growthfactors. J Clin Pathol 1992; 45: 461–464.
- Thiele J, Steinberg T, Zaukovich R, Fischer R. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis. Anticancer Res 1989; 9: 429–435.
- Leibovici M. Osteomyelosclerosis — A histopathological study of osteomedullary lesions on 32 cases. Morphol Embryol 1975; 21: 35–41.
- Bartl R, Frisch B, Wilmanns W. Potential of bone marrow biopsyin chronic myeloproliferative disorders (CMPD). Eur J Hematol 1993; 50: 41–52.
- Narayan S, Chandra J, Sharma S, Aiyer H. Idiopathic myelofi-brosis in children. Ind J Hemat & Blood Transf 2000; 4: 100–101.
- Sonkar S, Rani S, Rakheja D, Singh T. Primary and secondary myelofibrosis. Hematological and clinical findings in 69 cases. Ind J Hemat & Blood Transf 1998; 2: 47–51.
- Hasselbalch H, Jansen BA. Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance. Eur J Hematol 1990; 44: 172–178.
- Silverstein MN. Agnogenic Myeloid Metaplasia. Acton: Publishing Sciences Group, 1975.
- Visani G, Finilli C, Castelli U. Myelofibrosis with myeloid metaplasia: clinical and hematological parameters predicting survival in a series of 133 patients. Brit J Hematol 1990; 75: 4–9.
- Ward HP, Block MH. The natural history agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1971; 50: 357–420.
- Lisse I, Hasselbalch H, Junker P. Bone marrow stroma in idiopathic myelofibrosis and other hematological diseases. An immunohistochemical study. APIMS 1991; 99: 171–178.
- Cooley B, Lee P. A series of cases of splenomegaly in children withanemia and peculiar bone changes. Trans Am Pediatr Soc 1925; 37: 29–34.
- Phadke K, Dean S, Pitney WR. Platelet dysfunction in myelofi-brosis syndromes. Am J Heamt 1981; 10: 57–64.
- Raman BKS, Van Slyck EJ, Huddk J, Sawdyk MA, Abrahm IP, Saeed SM. Platelet function studies in MDD, MDS and secondary thrombocytosis. Am J Clin Path 1989; 95: 647–655.
- Balduni CL, Beitolino G, Non SP, Pletta GC. Platelet aggregation in PRP and WB in 120 patients with MPD. Am J Clin Path 1991; 95: 82–86.
- Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992; 80: 575–581.
- Orkin SH. Transcription factors that regulate lineage decisions. In: Stamatoy—annopoulos G, Majerus PW, Perlmutter R, Varmus H. (eds) The Molecular Basis of Blood Diseases. Philadelphia: WB Saunders, 2000; 80-102.
- Vannucchi AM, Binachi L, Cellai C et al. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1 low mice). Blood 2002; 100: 1123–1132.
- Gordon B. Immunologic abnormalities in myelofibrosis. Prog Clin Biol Res 1984; 154: 455–463.
- Rosenbaum DL, Murphy GW, Swisher SN. Hemodynamic studies of the portal circulation in myeloid metaplasia. Am J Med 1966; 41: 360–368.
- Bouroncle DA, Doan CA. Myelofibrosis. Clinical, hematological and pathologic study of 110 patients. Am J Med Sci 1962; 243: 697–718.
- Nakamma H, Sodamori N, Mine M. Effects of short term liquid culture of pheripheral blood mononuclear cells with recombinant human granulocyte or granulocyte macrophage colony-stimulating factors in cytogenetic studies of myelofibrosis with myeloid metaplasia. Leukemia 1992; 6: 853–855.